Thymosin Alpha-1 Cost: Complete 2026 Pricing Guide

By Brian Williams, Co-founder & Research EditorFact-checked by Megan WilliamsUpdated September 6, 2026
Quick Answer
$200–$500per month

Thymosin Alpha-1 therapy typically costs $200–$500 per month in the United States. Cash price through telehealth or compounding pharmacies is typically at the lower end; brand or in-person clinic programs at the higher end. Insurance coverage can reduce out-of-pocket cost to $25–$100/month when applicable.

What Drives Thymosin Alpha-1 Cost

Monthly Thymosin Alpha-1 pricing depends on five main factors:

  • FDA status: Thymosin Alpha-1 is currently Research. It is typically accessed through compounding pharmacies or clinical research settings. Insurance does not cover research peptides.
  • Dose: Higher doses use more peptide per month and cost more. Titration phases are usually cheaper than maintenance doses.
  • Channel: Brand retail pharmacy, manufacturer direct-to-patient programs, telehealth compounded, and in-person clinic programs price differently.
  • Clinic overhead: Provider consultation, monitoring, labs, and support are often bundled into monthly program pricing.
  • Geography: Regional cost of living affects in-person clinic pricing more than telehealth pricing.

Pricing Breakdown by Channel

ChannelTypical Monthly CostWhat’s Included
Telehealth (compounded)$200–$350Peptide + video consult + basic follow-up
In-person clinic$350–$500Peptide + exam + labs (when ordered) + follow-up
Insurance (when covered)$25–$100 copayPrior authorization typically required

Insurance Coverage

As a research peptide, Thymosin Alpha-1 is not covered by insurance. Patients pay out-of-pocket through telehealth or clinic programs. HSA and FSA funds can sometimes be used when prescribed for a qualifying medical purpose — verify with your benefits administrator and obtain an itemized invoice.

About “Cheap” Peptide Sources

Online research-chemical vendors sell Thymosin Alpha-1 at prices substantially below legitimate compounding pharmacy rates. These products lack FDA-regulated manufacturing, sterility testing, and quality assurance. Savings are real; safety is not. For injectable peptides, use a licensed 503A or 503B pharmacy through a qualified provider.

Thymosin Alpha-1 Pricing by State

Provider pricing varies by state. These are the states where we list Thymosin Alpha-1 providers, busiest first:

2 states currently list Thymosin Alpha-1 providers. Browse the full provider directory →

Compare immune support Peptide Pricing

Find a Thymosin Alpha-1 Provider

Browse 3 listed providers offering Thymosin Alpha-1 therapy. Filter by telehealth, location, and insurance acceptance.

Where to get Thymosin Alpha-1 with a prescription

Thymosin Alpha-1 requires a prescription and medical supervision. Each service below states that a licensed provider reviews your intake and prescribes through a US compounding pharmacy where appropriate. Those are the companies’ own descriptions of how they operate, not findings of ours. Compounded medications are not FDA-approved, and a consultation does not guarantee a prescription.

Some telehealth links below are affiliate links. If you buy through them, we may earn a commission at no extra cost to you. Commission never affects which products or clinics we list, how they are ordered, or what we say about them — see our editorial policy.

HealthRx — telehealth consultationAd

Says a board-certified physician reviews each intake and prescribes through a licensed 503A compounding pharmacy where appropriate, and lists a LegitScript certification. Compounded medications are not FDA-approved.

We are not a clinic and do not prescribe. Listing a service here is not a clinical endorsement of it, and you should confirm licensure and pharmacy sourcing yourself before treatment.

Stay Updated

Get notified when new peptide therapy providers join in your area.

Medical Disclaimer: This content is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider before beginning any peptide therapy treatment.